Efficacy of Rademikibart in COPD-like Patients: Sub-analyses from the Phase 2b Trial in Patients With Moderate-to-Severe Asthma
American Journal of Respiratory and Critical Care Medicine
May 1, 2025
Cited by 0
Related Papers
Myc activates telomerase
|Genes & Development|1998|659
Glycolytic Enzymes Can Modulate Cellular Life Span
|Cancer Research|2005|640
Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing
|Genes & Development|2015|278